Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1639.30
7.65 (0.47%)
< Home < Back

Sun Pharmaceutical Industries submits press release

Date: 06-11-2019

Sun Pharmaceutical Industries has informed about submission of its press release relating to License Agreement with AstraZeneca for Novel Oncology products in China, which it shall be releasing after sending this letter.

The above information is a part of company’s filings submitted to BSE.